Rallybio Corp Valuation
| RLYB Stock | USD 0.88 0.01 1.15% |
Today, the company appears to be undervalued. Rallybio Corp holds a recent Real Value of $2.7 per share. The prevailing price of the company is $0.88. Our model determines the value of Rallybio Corp from analyzing the company fundamentals such as Current Valuation of (38.55 M), return on equity of -0.67, and Shares Owned By Insiders of 4.05 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Rallybio Corp's valuation include:
Undervalued
Today
Please note that Rallybio Corp's price fluctuation is risky at this time. Calculation of the real value of Rallybio Corp is based on 3 months time horizon. Increasing Rallybio Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Rallybio Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Rallybio Stock. However, Rallybio Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.88 | Real 2.7 | Target 8.25 | Hype 0.87 | Naive 0.84 |
The real value of Rallybio Stock, also known as its intrinsic value, is the underlying worth of Rallybio Corp Company, which is reflected in its stock price. It is based on Rallybio Corp's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Rallybio Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Rallybio Corp helps investors to forecast how Rallybio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Rallybio Corp more accurately as focusing exclusively on Rallybio Corp's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Rallybio Corp's intrinsic value based on its ongoing forecasts of Rallybio Corp's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Rallybio Corp's closest peers. If more than one evaluation category is relevant for Rallybio Corp we suggest using both methods to arrive at a better estimate.
Rallybio Corp Cash |
|
Rallybio Valuation Trend
Comparing Rallybio Corp's enterprise value against its market capitalization is a good way to estimate the value of Rallybio Corp uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Rallybio Corp Total Value Analysis
Rallybio Corp is at this time anticipated to have valuation of (38.55 M) with market capitalization of 36.36 M, debt of 392 K, and cash on hands of 147.37 M. The negative valuation of Rallybio Corp may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Rallybio Corp fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(38.55 M) | 36.36 M | 392 K | 147.37 M |
Rallybio Corp Asset Utilization
One of the ways to look at asset utilization of Rallybio is to check how much profit was generated for every dollar of assets it reports. Rallybio Corp holds a negative application of assets of -0.39 pct., losing $0.003854 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Rallybio Corp shows how discouraging it operates for each dollar spent on its assets.Rallybio Corp Ownership Allocation
Rallybio Corp owns a total of 41.49 Million outstanding shares. The majority of Rallybio Corp outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Rallybio Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Rallybio Corp. Please pay attention to any change in the institutional holdings of Rallybio Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Rallybio Corp Profitability Analysis
Net Loss for the year was (74.56 M) with profit before overhead, payroll, taxes, and interest of 598 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Rallybio Corp's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Rallybio Corp and how it compares across the competition.
About Rallybio Corp Valuation
The stock valuation mechanism determines Rallybio Corp's current worth on a weekly basis. Our valuation model uses a comparative analysis of Rallybio Corp. We calculate exposure to Rallybio Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Rallybio Corp's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -135 K | -141.8 K |
Rallybio Corp Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 40.4 M |
Rallybio Corp Current Valuation Indicators
Valuation refers to the process of determining the present value of Rallybio Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Rallybio we look at many different elements of the entity such as Rallybio's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Rallybio Corp, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Rallybio Corp's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Rallybio Corp's worth.Complementary Tools for Rallybio Stock analysis
When running Rallybio Corp's price analysis, check to measure Rallybio Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rallybio Corp is operating at the current time. Most of Rallybio Corp's value examination focuses on studying past and present price action to predict the probability of Rallybio Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rallybio Corp's price. Additionally, you may evaluate how the addition of Rallybio Corp to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world |